Based on our previous findings that Spry1 in keratinocytes suppresses psoriasis-like skin inflammation by inhibiting cathelicidin production and cutaneous immune activation, we next examined the impact of Spry1 loss in epidermal keratinocytes (25). This evidence concerns the gene SPRY1 and psoriasis.